DocGo Gets 180-Day Nasdaq Extension to Regain $1 Bid Compliance
DCGO sits 44% above its 52-week low of $0.451 on light trading volume (0.2× avg).
Summary
Nasdaq granted DocGo an additional 180 days, until January 25, 2027, to regain compliance with the $1.00 minimum bid price rule. The company is evaluating options including a reverse stock split.
Key Events · Legal and Risk Events · DCGO
-
Nasdaq Extension Granted
DocGo received an additional 180 calendar days, until January 25, 2027, to regain compliance with the $1.00 minimum bid price requirement.
-
Compliance Path
The stock must close at or above $1.00 for at least 10 consecutive business days before the deadline to regain compliance.
-
Reverse Split on the Table
The company intends to evaluate options including a reverse stock split, which shareholders approved at the June 16, 2026 annual meeting at ratios between 1-for-5 and 1-for-10.
-
Ongoing Distress
This extension comes amid declining revenue, covenant breaches, and going-concern doubts disclosed in the Q1 2026 10-Q, making the listing fight existential.
Analysis · DCGO · Industrial Applications And Services
DocGo received a critical lifeline from Nasdaq, extending its deadline to January 25, 2027 to get the stock price back above $1.00. The company has been trading below $1 for months, and a delisting would be catastrophic for a company already dealing with declining revenue, covenant breaches, and going-concern doubts. The extension buys time, but the clock is ticking — if the stock doesn't recover, a reverse split is the likely next move, which shareholders already approved. This filing confirms the company is still in the danger zone, but the immediate delisting threat is pushed back.
At the time of this filing, DCGO was trading at $0.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $64.3M. The 52-week trading range was $0.45 to $1.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.